The levels of glutathione and nitrite-nitrate and the expression of BCL-2 mRNA in ovariectomized rats treated by raloxifene against kainic acid

International Journal of Neuroscience

Volumn 119, Issue 2, 2009, Pages 227-239

  Armagan, Guliz ^a   Kanit, Lutfiye ^a   Terek, Cosan M ^a   Sozmen, Eser Y ^a   Yalcin, Ayfer ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Bcl 2; Brain cortex; Glutathione; Kainic acid; Ovariectomy; Raloxifene

Indexed keywords

GLUTATHIONE; KAINIC ACID; NITRATE; NITRITE; PROTEIN BCL 2; RALOXIFENE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; FEMALE; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; OVARIECTOMY; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SEIZURE;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; FEMALE; GLUTATHIONE; KAINIC ACID; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; NITRATES; NITRIC OXIDE; NITRITES; OVARIECTOMY; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; RALOXIFENE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; RNA, MESSENGER; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 58149231170     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207450802330959     Document Type: Article

References (39)

1. Adams, J. M., & Cory, S. (1998). The Bcl-2 protein family: arbiters of cell survival. Science, 281(5381), 1322-1326.
2. Aizenman, E., Brimecombe, J. C., Potthoff, W. K., & Rosenberg, P. A. (1998). Why is the role of nitric oxide in NMDA receptor function and dysfunction so controversial? Progress in Brain Research, 118, 53-71.
3. Azcoitia, I., DonCarlos, L. L., & Garcia-Segura, L. M. (2002). Estrogen and brain vulnerability. Neurotoxicity Research, 4(3), 235-245.
4. Azcoitia, I., Fernandez-Galaz, C., Sierra, A., & Garcia-Segura, L. M. (1999). Gonadal hormones affect neuronal vulnerability to excitotoxin-induced degeneration. Journal of Neurocytology, 28(9), 699-710.
5. Bories, P. N., & Bories, C. (1995). Nitrate determination in the biological fluids by an enzymatic one-step assay with nitrate reductase. Clinical Chemistry, 41(6), 904-907.
6. Callier, S., Morissette, M., Grandbois, M., Pelaprat, D., & Di Paolo, T. (2001). Neuroprotective properties of 17beta-estrodiol, progesteron and raloxifene in MPTP C57B1/6 mice. Synapse, 41, 131-138.
7. Ceccon, M., Giusti, P., Facci, L., Borin, G., Imbesi, M., Floreani, M., et al.(2000). Intracellular glutathione levels determine cerebellar granule neuron sensitivity to excitotoxic injury by kainic acid. Brain Research, 862, 83-89.
8. Chomczynski, P. (1993). A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques, 15, 532-537.
9. Ciriza, I., Azcoitia, I., & Garcia-Segura, M. (2004). Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo. Journal of Neuroendocrinology, 16, 58-63.
10. Contestabile, A., & Ciani, E. (2004). Role of nitric oxide in the regulation of neuronal proliferation, survival and differentiation. Neurochemistry International, 45, 903-914.
11. Cooper, A. J., & Kristal, B. S. (1997). Multiple roles of glutathione in the central nervous system. Biological Chemistry, 378(89), 793-802.
12. Dawson, V. L., & Dawson, T. M. (1998). Nitric oxide in neurodegeneration. Progress in Brain Research, 118, 215-229.
13. Delen-Akcay, Y., Yalcin, A., & Yildirim-Sozmen, E. (2005). The effect of melatonin on lipid peroxidation and nitrite/nitrate levels, and on superoxide dismutase and catalase activities in kainic acid-induced injury. Cellular and Molecular Biology Letters, 10, 321-329.
14. Dringen, R. (2000). Metabolism and functions of glutathione in brain. Progress in Neurobiology, 62, 649-671.
15. Farinelli, S. E., Park, D. S., & Greene, L. A. (1996). Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism. Journal of Neuroscience, 16, 2325-2334.
16. Garcia-Segura, L. M., Azcoitia, I., & DonCarlos, L. L. (2001). Neuroprotection by estradiol. Progress in Neurobiology, 63, 29-60.
17. Gerlach, M., Ben-Shachar, D., Riederer, P., & Youdim, M. B. (1994). Altered brain metabolism of iron as a cause of neurodegenerative diseases? Journal of Neurochemistry, 63(3), 793-807.
18. Grandbois, M., Morissette, M., Callier, S., & Di Paolo, T. (2000). Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice. NeuroReport, 11, 343-346.
19. Hockenbery, D. M., Oltvai, Z. N., Yin, X. M., Milliman, C. L., & Korsmeyer, S. J. (1993). Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75, 241-251.
20. Howard, S., Bottino, C., Brooke, S., Cheng, E., Giffard, R. G., & Sapolsky, R. (2002). Neuroprotective effects of bcl-2 overexpression in hippocampal cultures: Interactions with pathways of oxidative damage. Jounal of Neurochemistry, 83, 914-993.
21. Jia, W., Wang, Y., Qiang, D., Tufaro, F., Remington, R., & Cynader, M. (1996). A bcl-2 expressing viral vector protects cortical neurons from excitotoxicity even when administered several hours after the toxic insult. Brain Research Molecular Brain Research, 42, 350-358.
22. Krishnan, M., & Dhandapani-Darrell, W. B. (2002). Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biology of Reproduction, 67, 1379-1385.
23. Lipton, S. A., Choi, Y. B., Sucher, N. J., & Chen, H. S. (1998). Neuroprotective versus neurodestructive effects of NO-related species. Biofactors, 8, 33-40.
24. Lowry, O. H., Rosenbrough, N. J., Farr, A. L., & Randall, R. J. (1951). Protein measurement with the folin-phenol reagent. Journal of Biological Chemistry, 193, 265-375.
25. Mannick, J. B., Asano, K., Izumi, K., Kieff, E., & Stamler, J. S. (1994). Nitric oxide produced by human B lymphocyte inhibits apoptosis and Epstein-Barr virus reactivation. Cell, 79(7), 1137-1146.
26. Marini, H., Altavilla, D., Bellomo, M., Adamo, E. B., Marini, R., Laureanti, F., et al. (2004). Modulation of IL-1 Beta gene expression by lipid peroxidation inhibition after kainic acid-induced rat brain injury. Experimental Neurology, 188, 178-186.
27. Mehta, S. H., Dhandapani, K. M., De Sevilla, D. M., Webb, R. C., Mabesh, V. B., & Brann, D. W. (2003). Tamoxifene, a selective estrogen receptor modulator, reduces ischemic damage caused by middle cerebral artery occlusion in the ovariectomized rats. Neuroendocrinology, 77, 44-50.
28. O'Neill, K., Chen, S., & Brinton, R. D. (2004). Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease. Experimental Neurology, 185, 63-80.
29. Oge, A., Sezer, E. D., Ozgonul, M., Bayraktar, F., & Sozmen, E. Y. (2003). The effects of estrogen and raloxifene treatment on the antioxidant enzymes and nitrite-nitrate levels in brain cortex of ovariectomized rats. Neuroscience Letters, 338, 217-220.
30. Osuka, K., Feustel, P. J., Mongin, A. A., Tranmer, B. I., & Kimelberg, H. K. (2001). Tamoxifene inhibits nitrotyrosine formation after reversible middle cerebral artery occlusion in the rat. Journal of Neurochemistry, 76, 1842-1850.
31. Ouyang, Y., & Giffard, R. G. (2004). Cellular neuroprotective mechanisms in cerebral ischemia: Bcl-2 family proteins and protection of mitochondrial function. Cell Calcium, 36, 303-311.
32. Phillips, R. G., Lawrence, M. S., Ho, D. Y., & Sapolsky, R. M. (2000). Limitations in the neuroprotective potential of gene therapy with Bcl-2. Brain Research, 859, 202-206.
33. Shimizu, S., Narita, M., & Tsujimoto, Y. (1999). Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature, 399(6735), 483-487.
34. Vander Heiden, M. G., Chandel, N. S., Williamson, E. K., Schumacker, P. T., & Thompson, C. B. (1997). Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell, 91, 627-637.
35. Velardez, M. O., Poliandri, A. H., Cabilla, J. P., Bodo, C. C. A., Machiavelli, L. I., & Duvilanski, B. H. (2004). Long term treatment of anterior pituitary cells with nitric oxide induces programmed cell death. Endocrinology, 145(4), 2064-2070.
36. Voehringer, D. W., & Meyn, R. E. (2000). Redox aspects of Bcl-2 function. Antioxidants & Redox Signalling, 2, 537-550.
37. Yalcin, A., Kanit, L., Durmaz, G., Sargin, S., Terek, C. H., & Tanyolac, B. (2005). Altered level of apurinic/apyrimidinic endonuclease/redox factor-1 (APE/REF-1) mRNA in the hippocampus of ovariectomized rats treated by raloxifene against kainic acid. Clinical and Experimental Pharmacology and Physiology, 32(8), 611-614.
38. Zhao, H., Yenari, M. A., Cheng, D., Sapolsky, R. M., & Steinberg, G. K. (2003). Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. Journal of Neurochemistry, 85, 1026-1036.
39. Zhao, L., O'Neill, K., & Brinton, R. D. (2005). Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs. Brain Research Reviews, 49(3), 472-493.